Skip to content
★ Sign in to follow
久裕

久裕 Stock: price and insider trades · Taiwan

TW·Mcap NT$1.3BHealth Care

久裕: what insiders have been doing

Only a handful of insider records exist for 久裕, the last one from 3 June 2016, too few to describe a trend. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 18,377 of 26,911 companies
39.4
score / 100
Value
41
Quality
38
FCF yld-144%
Earn yld6.5%
EV/EBITDA10.7x
ROE3.1%
Gross mgn20%
Net mgn5.6%
Debt/EBITDA3.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

NT$18
Analyst consensus
·
Income statement
RevenueNT$1.5B
Gross profitNT$310.6M20% margin
EBITDANT$184.2M12% margin
Net incomeNT$86.8M3.8% margin
Valuation
PER (trailing)22.2x
P/Book0.7x
Beta0.07
Balance sheet & cash
Market capNT$1.3B
Total debtNT$634M
Free Cash Flow-NT$1.9B
Debt / Equity21%
Profitability & ownership
ROE3.1%
ROA0.8%
% insiders45.1%
% institutions0.0%
Last declaration on 3 June 2016
Declarations5 total
  • ●
    Related company / holdingExecutives
    €929kest.0MOPS
    1,480,000 sharesShareTPExTWMOPS:4173:105/06/03:久裕投資股份有限公司:13qemqx
  • ●
    Related company / holdingExecutives
    €2.2Mest.0MOPS
    3,554,000 sharesShareTPExTWMOPS:4173:105/04/29:久裕投資股份有限公司:1x1xk9h
  • ●
    Related company / holdingExecutives
    €2.0Mest.0MOPS
    3,500,000 sharesShareTPExTWMOPS:4173:105/03/29:久裕投資股份有限公司:0r7zbdy
  • ●
    Related company / holdingExecutives
    €2.2Mest.0MOPS
    3,480,000 sharesShareTPExTWMOPS:4173:105/02/26:久裕投資股份有限公司:0m1jcq1
  • ●
    Related company / holdingExecutives
    €615kest.0MOPS
    1,000,000 sharesShareTPExTWMOPS:4173:105/01/28:久裕投資股份有限公司:07xjana

5 of 5 declarations

About 久裕

久裕 is a company listed on the XTAI market, specializing in the financial sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations